Inventor · disambiguated record
Wei Liu
Also filed as: LIU WEI · LIU WEI-HSIEN
30 granted patents·48 pending applications·200 citations·filing 2002–2025
96Inventor score
Files withWYETH CORP17INNER MONGOLIA YILI IND GROUP13ALKERMES PHARMA IRELAND LTD6WELICHEM BIOTECH INC3WYETH LLC3
Top patents by PatentIndex Score
78 records- 0194US11717481B2Reduction of flake-like aggregation in nanoparticulate active agent compositionsALKERMES PHARMA IRELAND LTD·Filed 2021·Granted Aug 8, 2023·2 cites·40 claims
- 0291US9345665B2Reduction of flake-like aggregation in nanoparticulate active agent compositionsALKERMES PHARMA IRELAND LTD·Filed 2013·Granted May 24, 2016·13 cites·14 claims
- 0391US7868047B2Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxy stilbenes and novel stilbene derivatives and analoguesWELICHEM BIOTECH INC·Filed 2007·Granted Jan 11, 2011·17 cites·3 claims
- 0490US7754689B2Finger-1 peptide analogs of the TGF-β superfamilyWYETH LLC·Filed 2007·Granted Jul 13, 2010·16 cites·8 claims
- 0590US7122361B2Compositions employing a novel human kinaseWYETH CORP·Filed 2003·Granted Oct 17, 2006·41 cites·2 claims
- 0688US7416849B2HBM variants that modulate bone mass and lipid levelsOSCIENT PHARMACEUTICALS CORP·Filed 2002·Granted Aug 26, 2008·36 cites·26 claims
- 0787US8487009B21,2-diphenylethene derivatives for treatment of immune diseasesCHEN GENHUI·Filed 2009·Granted Jul 16, 2013·15 cites·21 claims
- 0885US8435523B2Antibodies against nerve growth factor (NGF) with enhanced in vivo stabilityPOWELL JOHN·Filed 2010·Granted May 7, 2013·17 cites·9 claims
- 0984US11253478B2Reduction of flake-like aggregation in nanoparticulate active agent compositionsALKERMES PHARMA IRELAND LTD·Filed 2018·Granted Feb 22, 2022·1 cites·14 claims
- 1083US11298382B2Bifidobacterium lactis BL-99 and application thereofINNER MONGOLIA YILI IND GROUP·Filed 2021·Granted Apr 12, 2022·2 cites·6 claims
- 1183US7321050B2Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxy stilbenes and novel stilbene derivatives and analoguesWELICHEM BIOTECH INC·Filed 2004·Granted Jan 22, 2008·17 cites·18 claims
- 1280US9974746B2Reduction of flake-like aggregation in nanoparticulate active agent compositionsALKERMES PHARMA IRELAND LTD·Filed 2016·Granted May 22, 2018·2 cites·15 claims
- 1379US9988397B2ERK inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jun 5, 2018·2 cites·6 claims
- 1477US10435400B22,4-disubstituted phenylene-1,5-diamine derivatives and applications thereof, and pharmaceutical compositions and pharmaceutically acceptable compositions prepared therefromSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Oct 8, 2019·3 cites·9 claims
- 1575US7208306B2Compositions employing a novel human protein phosphataseWYETH CORP·Filed 2003·Granted Apr 24, 2007·6 cites·1 claims
- 1674US11911422B2Bifidobacterium lactis BL-99 and application thereofINNER MONGOLIA YILI IND GROUP·Filed 2022·Granted Feb 27, 2024·0 cites·15 claims
- 1774US11911423B2Bifidobacterium lactis BL-99 and application thereofINNER MONGOLIA YILI IND GROUP·Filed 2022·Granted Feb 27, 2024·0 cites·15 claims
- 1874US9974748B2Reduction of flake-like aggregation in nanoparticulate active agent compositionsALKERMES PHARMA IRELAND LTD·Filed 2016·Granted May 22, 2018·1 cites·15 claims
- 1974US9974747B2Reduction of flake-like aggregation in nanoparticulate active agent compositionsALKERMES PHARMA IRELAND LTD·Filed 2016·Granted May 22, 2018·1 cites·15 claims
- 2073US9884048B2ERK inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Feb 6, 2018·2 cites·6 claims
- 2171US7745164B2Methods of modulating apoptosis using inhibitors of brain-localized protein kinases homologous to homeodomain-interacting protein kinasesWYETH LLC·Filed 2006·Granted Jun 29, 2010·2 cites·4 claims
- 2270US10967013B2Lactic acid bacterium for prophylaxis or treatment of a stress-induced disorder and a composition containing the sameUNIV NAT YANG MING·Filed 2014·Granted Apr 6, 2021·1 cites·4 claims
- 2370US2025025519A1New use of bifidobacterium infantis ylgb-1496 in anti-aging and improvement of innate immunityINNER MONGOLIA YILI IND GROUP·Filed 2022·Application pending·0 cites
- 2470US2025041359A1Use of bifidobacterium lactis bl-99 in prevention and/or amelioration of gastritisINNER MONGOLIA YILI IND GROUP·Filed 2022·Application pending·0 cites
- 2569US2009022798A1Formulations of nonopioid and confined opioid analgesicsABBOTT GMBH & CO KG·Filed 2007·Application pending·0 cites
- 2668US2025195680A1Cancer treatment with anti-claudin 18.2 adcKEYMED BIOSCIENCES CHENGDU CO LTD·Filed 2024·Application pending·0 cites
- 2764US2013344143A1Formulations of nonopioid and confined opioid analgesicsABBVIE DEUTSCHLAND·Filed 2012·Application pending·0 cites
- 2864US2010094041A1Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxy stilbenes and novel stilbene derivatives and analoguesWELICHEM BIOTECH INC·Filed 2009·Application pending·0 cites
- 2962US8853367B1Compositions and methods for modulating rank activitiesFENG XU·Filed 2005·Granted Oct 7, 2014·3 cites·14 claims
- 3062US7297525B2Composition employing a novel human kinaseWYETH CORP·Filed 2003·Granted Nov 20, 2007·0 cites·1 claims
- 3160US11666613B2Use of Lactobacillus paracasei subsp. paracasei K56 capable of regulating gastrointestinal flora balanceINNER MONGOLIA YILI IND GROUP·Filed 2020·Granted Jun 6, 2023·0 cites·7 claims
- 3259US2024189371A1Application of Lactobacillus Paracasei Subsp. Paracasei K56 in Improving Intestinal Bacterial Infection Resistance and Intestinal ImmunityINNER MONGOLIA YILI IND GROUP·Filed 2021·Application pending·0 cites
- 3359US2010172989A1Abuse resistant melt extruded formulation having reduced alcohol interactionABBOTT LAB·Filed 2009·Application pending·0 cites
- 3458US2011229526A1Formulations of nonopioid and confined opioid analgesicsROSENBERG JOERG·Filed 2011·Application pending·0 cites
- 3558US2009232809A1Type 2 cytokine receptor and nucleic acids encoding sameWYETH CORP·Filed 2008·Application pending·0 cites
- 3657US7407792B2Compositions, organisms and methodologies employing a novel human kinaseWYETH CORP·Filed 2006·Granted Aug 5, 2008·0 cites·4 claims
- 3757US2008153147A1Compositions, organisms and methodologies employing a novel human kinaseWYETH CORP·Filed 2007·Application pending·0 cites
- 3855US2025177436A1Method for treating metabolic disorders by ileum-targeted delivery of endotoxin sequestrantSQ BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 3955US2009156537A1Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseasesWYETH CORP·Filed 2008·Application pending·0 cites
- 4055US2024376160A1Molecular peptide mutant with a high ester bond formation efficiencyNANJING UNIVERSITY OF TECHNOLOGY·Filed 2022·Application pending·0 cites
- 4155US2024002454A1Molecular peptide mutantNANJING UNIVERSITY OF TECHNOLOGY·Filed 2022·Application pending·0 cites
- 4254US2025025518A1Use of bifidobacterium lactis bl-99 in protection of cartilageINNER MONGOLIA YILI IND GROUP·Filed 2022·Application pending·0 cites
- 4354US2010316725A1Reduction of flake-like aggregation in nanoparticulate active agent compositionsELAN PHARMA INT LTD·Filed 2010·Application pending·0 cites
- 4454US2009136507A1HBM variants that modulate bone mass and lipid levelsOSCIENT PHARMACEUTICALS·Filed 2008·Application pending·0 cites
- 4554US2023218736A1Cocktail Vaccine of Recombinant African Swine Fever Virus (ASFV) Antigen and Use ThereofLANZHOU VETERINARY RES INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES·Filed 2022·Application pending·0 cites
- 4653US2004191818A1Compositions and methods for diagnosing and treating autoimmune diseasesFiled 2004·Application pending·0 cites
- 4753US2024091283A1Application of Lactobacillus Paracasei ET-22 In Improving Intestinal Bacterial Infection Resistance and Intestinal ImmunityINNER MONGOLIA YILI IND GROUP·Filed 2021·Application pending·0 cites
- 4853US2017014348A1Formulations of Nonopioid and Confined Opioid AnalgesicsABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 4952US2005214292A1Compositions and methods for diagnosing and treating autoimmune diseaseWYETH CORP·Filed 2003·Application pending·0 cites
- 5052US2023414680A1Novel Use of Bifidobacterium Lactis BL-99 in Fighting Aging and Improving Innate ImmunityINNER MONGOLIA YILI IND GROUP·Filed 2021·Application pending·0 cites
Showing the top 50 of 78 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wei Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →